MUSTIKA, Syifa. The Effectiveness of Elbasir/Grazoprevir in Hepatitis C Patients with Stage 5 Chronic Kidney Disease (CKD). The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, [S. l.], v. 25, n. 2, p. 121–127, 2024. DOI: 10.24871/2522024302. Disponível em: https://ina-jghe.com/index.php/jghe/article/view/952. Acesso em: 20 oct. 2026.